基本信息
浏览量:3
职业迁徙
个人简介
Prof. Schibli's research interestscover targeted tumor diagnosis and therapy using radiolabeled compounds. Apart from the chemical modification and radioactive labeling of molecules, his group emphasizes on the biological and pharmacological characterization and optimization of the radioactive compounds including non-invasive PET and SPET imaging. New, medically relevant radionuclides for his pre-clinical and clinical studies are produced at the cyclotron and neutron facilities of the ETH and the Paul Scherrer Institute
Prof. Roger Schibli is an Associate Professor in the Department of Chemistry and Applied Biosciences (ETH Zurich) since 2010, and Head of the Center for Radiopharmaceutical Science (CRS), a joint endeavor between the ETH Zurich, the Paul Scherrer Institute and the University Hospital Zurich. Prof. Schibli studied Chemistry at the University of Basel, Switzerland and performed his doctoral thesis under the supervision of Prof. Thomas Kaden. After his graduation, he spent two years at the University of Missouri-Columbia, MO as a post-doctoral fellow. He was appointed Assistant Professor (tenure track) for Therapeutics Technologies at the Institute of Pharmaceutical Sciences (ETH Zurich) in 2004 and was tenured in 2009.
Prof. Roger Schibli is an Associate Professor in the Department of Chemistry and Applied Biosciences (ETH Zurich) since 2010, and Head of the Center for Radiopharmaceutical Science (CRS), a joint endeavor between the ETH Zurich, the Paul Scherrer Institute and the University Hospital Zurich. Prof. Schibli studied Chemistry at the University of Basel, Switzerland and performed his doctoral thesis under the supervision of Prof. Thomas Kaden. After his graduation, he spent two years at the University of Missouri-Columbia, MO as a post-doctoral fellow. He was appointed Assistant Professor (tenure track) for Therapeutics Technologies at the Institute of Pharmaceutical Sciences (ETH Zurich) in 2004 and was tenured in 2009.
研究兴趣
论文共 142 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yingfang He, Aro Delparente, Caitlin V M L Jie,Claudia Keller,Roland Humm, Dominik Heer,Ludovic Collin,Roger Schibli,Luca Gobbi,Uwe Grether,Linjing Mu
Chembiochem : a European journal of chemical biologyno. 7 (2024): e202300819-e202300819
ALZHEIMERS RESEARCH & THERAPYno. 1 (2024)
Belinda Trachsel,Stefan Imobersteg,Giulia Valpreda,Gad Singer, Regula Grabherr, Mark Ormos,Irene A. Burger,Rahel A. Kubik-Huch,Roger Schibli,Viola Vogel,Martin Béhé
EJNMMI Researchno. 1 (2024): 1-11
Julia Fricke, Frida Westerbergh,Lisa McDougall,Chiara Favaretto,Emanuel Christ,Guillaume P. Nicolas,Susanne Geistlich,Francesca Borgna,Melpomeni Fani,Peter Bernhardt,Nicholas P. van der Meulen,Cristina Müller,
European Journal of Nuclear Medicine and Molecular Imagingpp.1-3, (2024)
Yingfang He, Aro Delparente, Caitlin V. M. L. Jie,Claudia Keller,Roland Humm,Dominik Heer,Ludovic Collin,Roger Schibli,Luca Gobbi,Uwe Grether,Linjing Mu
Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler,Peter Bernhardt, Fabienne Fluehmann, Julia Fricke,Jan Rijn Zeevaart,Ulli Koester,Nicholas P. van der Meulen,Roger Schibli, Cristina Mueller
crossref(2024)
The Journal of Nuclear Medicineno. 6 (2023): 873-879
Journal of nuclear medicine : official publication, Society of Nuclear Medicineno. 7 (2023): 1138-1144
引用0浏览0WOS引用
0
0
Chiara Favaretto,Pascal Grundler,Zeynep Talip,Jan Zeevaart,Stefan Landolt,David Schmid,Susanne Geistlich, Cristina Mueller,Roger Schibli,Damian Wild, Nicholas van der Meulen
Tina Pekeč,Saradha Venkatachalapathy, Anne R. Shim, Daniel Paysan,Michal Grzmil,Roger Schibli,Martin Béhé,G. V. Shivashankar
Scientific Reportsno. 1 (2023): 1-14
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn